# Nasal Oxygen Therapy After Cardiac Surgery

Study · id `cardio:ct-nct05308719` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05308719](<https://clinicaltrials.gov/study/NCT05308719>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05308719

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1280 participants.

## Technical summary

Registry record NCT05308719. Randomized; single masking; primary purpose supportive care. Start 2020-09-08 (actual); primary completion 2024-12-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 1280 participants (enrolled count; ClinicalTrials.gov record NCT05308719, source copy `cardio:ctgov-nct05308719-2025-05-29`, retrieved 2026-10-26)
- Started: 2020-09-08 (actual) (ClinicalTrials.gov record NCT05308719, source copy `cardio:ctgov-nct05308719-2025-05-29`, retrieved 2026-10-26)
- Primary completion: 2024-12-06 (actual) (ClinicalTrials.gov record NCT05308719, source copy `cardio:ctgov-nct05308719-2025-05-29`, retrieved 2026-10-26)
- Completion: 2024-12-06 (actual) (ClinicalTrials.gov record NCT05308719, source copy `cardio:ctgov-nct05308719-2025-05-29`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05308719, source copy `cardio:ctgov-nct05308719-2025-05-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05308719-2025-05-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Nasal Oxygen Therapy After Cardiac Surgery
- Acronym: NOTACS
- Condition: Cardiac Valve Disease
- Condition: Coronary Artery Disease
- Condition: Respiratory Failure
- Intervention (Device): High Flow Nasal Therapy
- Lead sponsor: Papworth Hospital NHS Foundation Trust
- Lead sponsor class: OTHER\_GOV
- Collaborator: University Hospitals, Leicester
- Collaborator class: OTHER
- Collaborator: King's College London
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Papworth Hospital NHS Foundation Trust (`cardio:org-papworth-hospital-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: King's College London (`cardio:org-king-s-college-london`)

## Provenance

Content hash: cf23ce851cf43e99253e667b5572ca533067150fd247e06154c42272fba799e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
